# A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT

Study · id `cardio:ct-nct03716011` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03716011](<https://clinicaltrials.gov/study/NCT03716011>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03716011

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2700 participants.

## Technical summary

Registry record NCT03716011. Allocation not applicable; no masking; primary purpose treatment. Start 2018-12-20 (anticipated); primary completion 2021-12-20 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 2700 participants (planned count; ClinicalTrials.gov record NCT03716011, source copy `cardio:ctgov-nct03716011-2018-10-23`, retrieved 2026-10-26)
- Planned start: 2018-12-20 (anticipated) (ClinicalTrials.gov record NCT03716011, source copy `cardio:ctgov-nct03716011-2018-10-23`, retrieved 2026-10-26)
- Primary completion: 2021-12-20 (anticipated) (ClinicalTrials.gov record NCT03716011, source copy `cardio:ctgov-nct03716011-2018-10-23`, retrieved 2026-10-26)
- Completion: 2025-12-20 (anticipated) (ClinicalTrials.gov record NCT03716011, source copy `cardio:ctgov-nct03716011-2018-10-23`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03716011, source copy `cardio:ctgov-nct03716011-2018-10-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03716011-2018-10-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT
- Condition: Coronary Artery Disease
- Intervention (Device): EXCROSSAL
- Lead sponsor: JW Medical Systems Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: JW Medical Systems Ltd (`cardio:org-jw-medical-systems-ltd`)

## Provenance

Content hash: 50fd636a5fa96c1f4f88b708b7e297b55c0eb9dc18033cc4b8610780bcea3be7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
